Clinical trial
MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
NCT00187941 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00187941 |
|---|---|
| Title | MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression |
| Official title | Pilot Trial for Implementation of a Medroxyprogesterone(MPA)Pharmacokinetic(PK) Monitoring Strategy in Patients on Mycophenolate Mofetil(MMF)/FK Based Immunosuppression. |
| Lead sponsor | University of Florida, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Transplantation, Renal, Immunosuppression |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil |
| Enrollment | 22 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: